The Pharmacotherapy of the HeartMate II, a Continuous Flow Left Ventricular Assist Device, in Patients with Advanced Heart Failure: Integration of Disease, Device, and Drug

2010 ◽  
Vol 44 (10) ◽  
pp. 1647-1650 ◽  
Author(s):  
Douglas L Jennings ◽  
Rachel M Chambers ◽  
Jessica M Schillig
Keyword(s):  
Heart Failure ◽  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Continuous Flow ◽  
Left Ventricular ◽  
Advanced Heart Failure ◽  
Assist Device ◽  
Heartmate Ii ◽  
Ventricular Assist ◽  
Left Ventricular Assist

Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device

2018 ◽  
pp. 95-101
Author(s):  
David M. Dudzinski ◽  
James Sawalla Guseh
Keyword(s):  
Heart Failure ◽  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Continuous Flow ◽  
Left Ventricular ◽  
Advanced Heart Failure ◽  
Assist Device ◽  
Ventricular Assist ◽  
Clinical Endpoints ◽  
Left Ventricular Assist

This chapter provides a summary of the landmark study entitled “Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device.” This study and this chapter explores how a second-generation continuous-flow left ventricular assist device compares with a first generation pulsatile-flow device with regard to the clinical endpoints of survival, freedom from stroke, and freedom from device exchange. Starting with this comparison, this chapter describes the study basics, including funding, study location, who was studied, patient numbers, study design, study intervention, follow-up, endpoints, results, criticisms, and limitations. The chapter briefly reviews other relevant studies and related topics while discussing implications. It concludes with a relevant clinical case.

Sign in / Sign up

Export Citation Format

Share Document